Menu

• Ask a Health Expert about CHOLANGITIS
• Post Your Side Effect related to CHOLANGITIS
• CHOLANGITIS and FDA Warnings
• CHOLANGITIS in Patients Wiki
• Report CHOLANGITIS in Drug Side Effect Survey

CHOLANGITIS side effect

What is CHOLANGITIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Gemzar Side Effects Report #5647036-0
Physician from JAPAN reported GEMZAR problem on Feb 25, 2008. Male patient, 65 years of age, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, . GEMZAR dosage: 1000 MG, UNK. Patient was hospitalized. Patient recovered.

Alendronic Side Effects Report #5648342-6
ALENDRONIC ACID problem was reported by a Health Professional from UNITED KINGDOM on Feb 19, 2008. Female patient, 60 years of age, weighting 105.8 lb, was diagnosed with osteoporosis and was treated with ALENDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: cholangitis, hyponatraemia, pyrexia, . ALENDRONIC ACID dosage: unknown. Patient recovered.

Simulect Side Effects Report #5648474-2
Consumer or non-health professional from JAPAN reported SIMULECT problem on Feb 27, 2008. Female patient, child 1 years of age, was diagnosed with liver and small intestine transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: cholangitis, epstein-barr virus infection, hepatic steatosis, lymphoproliferative disorder, septic shock, . SIMULECT dosage: unknown. During the same period patient was treated with PROGRAF. Patient died.

Capecitabine Side Effects Report #5648773-4
CAPECITABINE problem was reported by a Physician from JAPAN on Feb 21, 2008. Male patient, 64 years of age, weighting 125.7 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . CAPECITABINE dosage: unknown. During the same period patient was treated with TRASTUZUMAB, CISPLATIN, FLUNITRAZEPAM, REBAMIPIDE, ETIZOLAM. Patient was hospitalized. Patient recovered.


Sorafenib Side Effects Report #5653239-1
Physician from BELGIUM reported SORAFENIB problem on Feb 29, 2008. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: cholangitis, pseudomonal sepsis, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Prednisolone Side Effects Report #5656019-6
PREDNISOLONE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 26, 2008. Female patient, weighting 189.6 lb, was diagnosed with rheumatoid arthritis and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholelithiasis, streptococcal sepsis, . PREDNISOLONE dosage: DAILY DOSE:10MG. During the same period patient was treated with ETANERCEPT, ALENDRONATE, DIGOXIN, DICLOFENAC, ASPIRIN, AMITRIPTYLINE, CALCIUM CARBONATE, ACETAMINOPHEN. Patient died on 04/12/2007.

Simulect Side Effects Report #5657978-8
Consumer or non-health professional from JAPAN reported SIMULECT problem on Mar 06, 2008. Female patient, weighting 21.83 lb, was diagnosed with liver and small intestine transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: cholangitis, epstein-barr virus infection, hepatic steatosis, intestinal villi atrophy, lymphoproliferative disorder, mucosal exfoliation, septic shock, . SIMULECT dosage: unknown. During the same period patient was treated with PROGRAF, STEROIDS NOS. Patient died.

Byetta Side Effects Report #5660765-8
BYETTA problem was reported by a Physician from UNITED STATES on Mar 03, 2008. Male patient was diagnosed with diabetes mellitus, rheumatoid arthritis and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: cholangitis, escherichia bacteraemia, gallbladder fistula, sepsis, . BYETTA dosage: unknown. During the same period patient was treated with ACTOS, METFORMIN, FOLIC ACID, MOBIC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5673230-9
Physician from JAPAN reported GEMZAR problem on Mar 12, 2008. Male patient, 48 years of age, was diagnosed with bile duct cancer non-resectable and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, . GEMZAR dosage: 2000 MG, OTHER. Patient died.


Gemzar Side Effects Report #5673246-2
GEMZAR problem was reported by a Physician from JAPAN on Mar 12, 2008. Female patient, 36 years of age, was diagnosed with bile duct cancer non-resectable and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, hepatic function abnormal, malignant neoplasm progression, . GEMZAR dosage: 1400 MG, OTHER. Patient died.

Gemzar Side Effects Report #5673247-4
Physician from JAPAN reported GEMZAR problem on Mar 12, 2008. Female patient, 78 years of age, was diagnosed with bile duct cancer non-resectable and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, . GEMZAR dosage: 1000 MG, OTHER. Patient died.

Sorafenib Side Effects Report #5674138-5
SORAFENIB problem was reported by a Physician from BELGIUM on Mar 13, 2008. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: cholangitis, pseudomonal sepsis, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient recovered.

Zetia Side Effects Report #5679128-4
Physician from JAPAN reported ZETIA problem on Mar 14, 2008. Male patient, 84 years of age, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: cholangitis, pancreatitis acute, sepsis, . ZETIA dosage: unknown. During the same period patient was treated with CRESTOR. Patient died.

Prograf Side Effects Report #5679809-2
PROGRAF problem was reported by a Physician from JAPAN on Mar 05, 2008. Female patient, weighting 21.83 lb, was diagnosed with small intestine transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cholangitis, epstein-barr virus test positive, hepatic steatosis, pleural effusion, post transplant lymphoproliferative disorder, septic shock, . PROGRAF dosage: unknown. During the same period patient was treated with STEROID, SIMULECT. Patient died on 11/16/2003.


Erlotinib Side Effects Report #5681115-7
Physician from FRANCE reported ERLOTINIB problem on Mar 11, 2008. Male patient, 50 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: cholangitis, hepatic haematoma, . ERLOTINIB dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5610755-6
CISPLATIN problem was reported by a Consumer or non-health professional from IRELAND on Jan 31, 2008. Male patient, 60 years of age, was diagnosed with gastric cancer, cancer pain, diabetes mellitus, constipation, prophylaxis of nausea and vomiting, stomatitis and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, upper gastrointestinal haemorrhage, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, INFUMORPH, GLICLAZIDE, METFORMIN, DOMPERIDONE, ORAMORPH, DIFFLAM. Patient was hospitalized. Patient died on 02/27/2006.

Capecitabine Side Effects Report #5612467-1
Physician from GERMANY reported CAPECITABINE problem on Jan 21, 2008. Male patient, 63 years of age, weighting 202.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, . CAPECITABINE dosage: PATIENT WAS IN ARM A: 2,500 MG/M2/DAY DIVIDED UP INTO 2 INDIVIDUAL DOSES (1,250 MG/M2 EACH), 2 WEEK+. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5625771-8
GEMCITABINE problem was reported by a Physician from JAPAN on Feb 01, 2008. Female patient, weighting 107.6 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . GEMCITABINE dosage: 1200 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON. Patient was hospitalized. Patient recovered.

Fosamax Side Effects Report #5632151-8
Health Professional from UNITED KINGDOM reported FOSAMAX problem on Feb 15, 2008. Female patient, 60 years of age, weighting 105.8 lb, was diagnosed with osteoporosis, benign pancreatic neoplasm and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: cholangitis, hyponatraemia, pyrexia, . FOSAMAX dosage: unknown. During the same period patient was treated with PANCREATIN, URSODIOL. Patient recovered.


Prograf Side Effects Report #5639224-4
PROGRAF problem was reported by a Physician from JAPAN on Feb 08, 2008. Female patient, child 4 years of age, weighting 47.40 lb, was diagnosed with renal and liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cholangitis, haemodialysis, multi-organ failure, sepsis, transplant rejection, . PROGRAF dosage: 0.015 MG, CONTINUOUS, IV DRIP. During the same period patient was treated with MEDROL, CELLCEPT, RITUXAN. Patient died on 06/28/2007.

Alendronic Side Effects Report #5646580-X
Consumer or non-health professional from UNITED KINGDOM reported ALENDRONIC ACID problem on Feb 15, 2008. Female patient, 60 years of age, was diagnosed with osteoporosis and was treated with ALENDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: cholangitis, hyponatraemia, . ALENDRONIC ACID dosage: 70 MG, ORAL. During the same period patient was treated with CREON, URSODIOL. Patient recovered.

Gemcitabine Side Effects Report #5583143-9
GEMCITABINE problem was reported by a Physician from JAPAN on Dec 25, 2007. Female patient, weighting 107.6 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . GEMCITABINE dosage: 1200 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON. Patient was hospitalized. Patient recovered.

Pioglitazone Side Effects Report #5583159-2
Pharmacist from UNITED STATES reported PIOGLITAZONE problem on Jan 03, 2008. Male patient, 80 years of age, was diagnosed with diabetes mellitus and was treated with PIOGLITAZONE. After drug was administered, patient experienced the following problems/side effects: cholangitis, oedema peripheral, . PIOGLITAZONE dosage: unknown. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5591010-X
CETUXIMAB problem was reported by a Health Professional from UNITED STATES on Jan 11, 2008. Male patient, weighting 153.2 lb, was diagnosed with pancreatic carcinoma and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: cholangitis, stent occlusion, . CETUXIMAB dosage: 250 MG/M2 WEEKLY IV. During the same period patient was treated with GEMZAR, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5592664-4
Physician from UNITED STATES reported PROGRAF problem on Jan 07, 2008. Male patient, 40 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholangitis chronic, disease recurrence, enterococcal infection, escherichia sepsis, heart rate increased, post procedural bile leak, septic shock, . PROGRAF dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISOLONE ACETATE, LAMIVUDINE, OMEPRAZOLE, INSULIN. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5594503-4
SORAFENIB problem was reported by a Physician from BELGIUM on Jan 11, 2008. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: cholangitis, neutropenia, pseudomonal sepsis, . SORAFENIB dosage: UNIT DOSE: 400 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5602033-6
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 22, 2008. Male patient, 51 years of age, weighting 180.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cholangitis, stent occlusion, . BEVACIZUMAB dosage: 830MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Tab Side Effects Report #5621288-5
TAB RALTEGRAVIR problem was reported by a Consumer or non-health professional from AUSTRALIA on Jan 18, 2008. Male patient, 45 years of age, was diagnosed with hiv infection and was treated with TAB RALTEGRAVIR. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholestasis, hepatic necrosis, hepatosplenomegaly, hepatotoxicity, hyperglycaemia, . TAB RALTEGRAVIR dosage: 400 MG/BID PO. During the same period patient was treated with ETRAVIRINE, DEXAMETHASONE, DARUNAVIR, LAMIVUDINE, RITONAVIR, TENOFOVIR DISOPROXIL FUMARATE. Patient was hospitalized. Patient recovered.

Simvastatin Side Effects Report #5533582-7
Consumer or non-health professional from RUSSIAN FEDERATION reported SIMVASTATIN problem on Nov 22, 2007. Male patient, 69 years of age, weighting 242.5 lb, was diagnosed with hypercholesterolaemia, myocardial ischaemia, hypertension, prophylaxis, arterial thrombosis and was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholecystitis acute, cholestasis, dehydration, peritonitis, poisoning, . SIMVASTATIN dosage: unknown. During the same period patient was treated with ZOFENOPRIL, METOPROLOL, PLAVIX, ASPIRIN. Patient was hospitalized. Patient died on 09/22/2006.

Enbrel Side Effects Report #5534724-X
ENBREL problem was reported by a Physician from UNITED KINGDOM on Nov 22, 2007. Female patient, weighting 189.6 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholelithiasis, streptococcal sepsis, surgery, . ENBREL dosage: unknown. During the same period patient was treated with PREDNISOLONE, ALENDRONATE, DIGOXIN, DICLOFENAC, ACETYLSALICYLIC ACID SRT, AMITRIPTLINE, ADCAL D, PARACETAMOL. Patient was hospitalized. Patient died on 04/12/2007.

Sorafenib Side Effects Report #5535676-9
Physician from BELGIUM reported SORAFENIB problem on Nov 30, 2007. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: cholangitis, neutropenia, pseudomonal sepsis, . SORAFENIB dosage: UNIT DOSE: 400 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Neoral Side Effects Report #5549554-2
NEORAL problem was reported by a Physician from ITALY on Dec 03, 2007. Male patient, 58 years of age, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . NEORAL dosage: 125 MG, BID. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5557940-X
Physician from GERMANY reported CAPECITABINE problem on Dec 04, 2007. Male patient, 63 years of age, weighting 202.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, . CAPECITABINE dosage: PATIENT WAS IN ARM A: 2,500 MG/M2/DAY DIVIDED UP INTO 2 INDIVIDUAL DOSES (1,250 MG/M2 EACH), 2 WEEK+. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5564505-2
GEMCITABINE problem was reported by a Physician from JAPAN on Dec 06, 2007. Female patient, weighting 133.8 lb, was diagnosed with bile duct cancer, insomnia, gastritis and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, platelet count decreased, . GEMCITABINE dosage: 800 MG, OTHER. During the same period patient was treated with DEPAS, GASTER D. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5570185-2
Physician from FRANCE reported VELCADE problem on Dec 04, 2007. Female patient, 73 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cholangitis, . VELCADE dosage: 2.50 MG,. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5504049-7
CYCLOSPORINE problem was reported by a Physician from ITALY on Oct 19, 2007. Male patient, 58 years of age, was diagnosed with liver transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . CYCLOSPORINE dosage: 125 MG, BID. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5504576-2
Physician from ITALY reported CYCLOSPORINE problem on Oct 19, 2007. Male patient, 58 years of age, was diagnosed with liver transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . CYCLOSPORINE dosage: 125 MG, BID. Patient was hospitalized. Patient recovered.

Metformin Side Effects Report #5505029-8
METFORMIN problem was reported by a Health Professional from UNITED STATES on Oct 29, 2007. Male patient, 63 years of age, was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholecystitis chronic, hepatitis, . METFORMIN dosage: unknown. During the same period patient was treated with GLYBURIDE, ALLOPURINOL, ASPIRIN. Patient recovered.

Metformin Side Effects Report #5509081-5
Health Professional from UNITED STATES reported METFORMIN HYDROCHLORIDE problem on Oct 24, 2007. Female patient was treated with METFORMIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: cholangitis, . METFORMIN HYDROCHLORIDE dosage: 500 MG, BID. During the same period patient was treated with GLYBURIDE, ALLOPURINOL, ASPIRIN. Patient recovered.

Cetuximab Side Effects Report #5513132-1
CETUXIMAB problem was reported by a Health Professional from GERMANY on Nov 01, 2007. Male patient, 67 years of age, was diagnosed with metastatic gastric cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: cholangitis, . CETUXIMAB dosage: 772MG LOADING DOSE 1 DAY ONCE GIVEN IV ON 27FEB07.ON 06MAR07-09OCT07 482.5 MG 1 IN 1 W (217 DAYS).. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, FOLINIC ACID. Patient was hospitalized. Patient recovered.

Metformin Side Effects Report #5515856-9
Consumer or non-health professional from GERMANY reported METFORMIN problem on Nov 05, 2007. Male patient, 63 years of age, was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholecystitis chronic, hepatitis, . METFORMIN dosage: unknown. During the same period patient was treated with GLYBURIDE, ALLOPURINOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Simvastatin Side Effects Report #5521235-0
SIMVASTATIN problem was reported by a Consumer or non-health professional from RUSSIAN FEDERATION on Nov 07, 2007. Male patient, 69 years of age, weighting 242.5 lb, was diagnosed with hypercholesterolaemia, myocardial ischaemia, hypertension, prophylaxis, arterial thrombosis and was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholecystitis acute, cholestasis, dehydration, peritonitis, poisoning, . SIMVASTATIN dosage: unknown. During the same period patient was treated with ZOFENOPRIL, METOPROLOL TARTRATE, METOPROLOL TARTRATE, PLAVIX, ASPIRIN. Patient was hospitalized. Patient died on 09/22/2006.

Cisplatin Side Effects Report #5526389-8
Consumer or non-health professional from IRELAND reported CISPLATIN problem on Nov 26, 2007. Male patient, 60 years of age, was diagnosed with gastric cancer, cancer pain, diabetes mellitus, constipation, prophylaxis of nausea and vomiting, stomatitis and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, upper gastrointestinal haemorrhage, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, INFUMORPH, GLICLAZIDE, METFORMIN, DOMPERIDONE, ORAMORPH, DIFFLAM. Patient was hospitalized. Patient died on 02/27/2006.

Fortamet Side Effects Report #5527422-X
FORTAMET problem was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Male patient, 63 years of age, was treated with FORTAMET. After drug was administered, patient experienced the following problems/side effects: cholangitis, hepatic fibrosis, hepatic necrosis, hepatitis, portal triaditis, . FORTAMET dosage: 500 MG, BID X 4 WEEKS, ORAL. During the same period patient was treated with GLYBURIDE, ALLOPURINOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Metformin Side Effects Report #5530877-8
Health Professional from UNITED STATES reported METFORMIN HYDROCHLORIDE problem on Nov 16, 2007. Female patient was treated with METFORMIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: cholangitis, . METFORMIN HYDROCHLORIDE dosage: 500 MG, BID. During the same period patient was treated with GLYBURIDE, ALLOPURINOL, ASPIRIN. Patient recovered.

Velcade Side Effects Report #5534373-3
VELCADE problem was reported by a Physician from FRANCE on Nov 20, 2007. Female patient, weighting 141.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cholangitis, . VELCADE dosage: 2.50 MG. During the same period patient was treated with CYTARABINE. Patient recovered.

Gemzar Side Effects Report #5478570-4
Physician from JAPAN reported GEMZAR problem on Sept 26, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . GEMZAR dosage: 1000 MG, UNK. Patient recovered.

Fosamax Side Effects Report #5481936-X
FOSAMAX problem was reported by a Pharmacist from JAPAN on Oct 04, 2007. Female patient, 89 years of age, was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: cholangitis, somnolence, . FOSAMAX dosage: unknown. During the same period patient was treated with NORVASC, TIMOPTIC, DIGOSIN, TICLOPIDINE HYDROCHLORIDE, ALFACALCIDOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5485432-5
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Oct 03, 2007. Male patient, 64 years of age, was diagnosed with adenocarcinoma pancreas, pain and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cholangitis, cholecystitis acute, cholelithiasis, hypotension, ileus, malnutrition, pharyngitis, renal failure acute, sepsis, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with GEMCITABINE, CREON, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ALLOPURINOL, PRAVACHOL, PROTONIX, QUINAPRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5493462-2
GEMZAR problem was reported by a Physician from JAPAN on Oct 10, 2007. Male patient, 65 years of age, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . GEMZAR dosage: 1000 MG, UNK. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5494997-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Oct 12, 2007. Female patient, weighting 229.3 lb, was diagnosed with pancreatic carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cholangitis, pyrexia, . BEVACIZUMAB dosage: 1040 MG, UNK. During the same period patient was treated with GEMCITABINE, PROTONIX. Patient was hospitalized. Patient recovered.